A 1996 follow-up survey by the Musculoskeletal Tumor Society in which 25 surgeons from 21 institutions submitted biopsy data on 597 primary sarcoma patients. The study asked whether complication and error rates had improved in the eleven years since their landmark 1982 report. It directly tests whether published recommendations changed practice.
A 24-year-old presents with a painless thigh mass. The outside surgeon wants to biopsy it locally before referring. This paper is the reason you say no. Biopsies of suspected sarcomas at non-specialist institutions carry 2–12 times higher rates of diagnostic errors, complications, and adverse outcomes — including unnecessary amputations. Compared to biopsies done at tumor treatment centers.
When you encounter a suspected bone or soft-tissue sarcoma, the referral happens before the biopsy. Not after. The data are unambiguous: 36.3% of patients biopsied at referring institutions required altered treatment vs. 4.1% at treatment centers.
A transverse biopsy incision on an extremity is the classic avoidable error. It contaminates a wider tissue compartment and can convert a limb-salvage case into an amputation or require free flap closure over an irradiated field.
This paper also established that improved imaging technology alone does not reduce biopsy error rates. The surgeon and pathologist's experience with sarcomas is the critical variable.
A 1996 follow-up survey by the Musculoskeletal Tumor Society in which 25 surgeons from 21 institutions submitted biopsy data on 597 primary sarcoma patients. The study asked whether complication and error rates had improved in the eleven years since their landmark 1982 report. It directly tests whether published recommendations changed practice.
A 24-year-old presents with a painless thigh mass. The outside surgeon wants to biopsy it locally before referring. This paper is the reason you say no. Biopsies of suspected sarcomas at non-specialist institutions carry 2–12 times higher rates of diagnostic errors, complications, and adverse outcomes — including unnecessary amputations. Compared to biopsies done at tumor treatment centers.
When you encounter a suspected bone or soft-tissue sarcoma, the referral happens before the biopsy. Not after. The data are unambiguous: 36.3% of patients biopsied at referring institutions required altered treatment vs. 4.1% at treatment centers.
A transverse biopsy incision on an extremity is the classic avoidable error. It contaminates a wider tissue compartment and can convert a limb-salvage case into an amputation or require free flap closure over an irradiated field.
This paper also established that improved imaging technology alone does not reduce biopsy error rates. The surgeon and pathologist's experience with sarcomas is the critical variable.